Latest Working Capital News

Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.

Green360 Technologies has kicked off commercial production of its low-carbon Eco-Clay cement alternative through a capital-light tolling agreement with Calix, while securing federal grant funding and a $4.5 million placement to fuel growth.

Riedel Resources has confirmed high-grade gold and silver at its Kingman Project with new drilling results and advanced exploration plans, while moving to acquire controlling interests in two large Western Australian gold projects backed by a $2.5 million equity raise.

Finder Energy has secured A$27 million via a two-tranche placement plus a A$3 million share purchase plan to fast-track its KTJ oil project in Timor-Leste, aiming for final investment decision by mid-2026 and first oil by late 2027.

Eden Innovations has expanded its EdenCrete Pz7 installations across North America, launched a new defence-focused division EdenShield, and eliminated costly debt, positioning for growth with a $4 million capital raise.

Alexium International Group has boosted sales to $1.03 million following its Microtek Laboratories acquisition, shifting focus to manufacturing-led growth and expanding its flame-retardant and thermal regulation product lines.

Liontown Limited delivered its strongest financial quarter since production began, achieving a self-funded quarter with a $33 million cash boost and surpassing underground mining targets ahead of schedule, while maintaining FY2026 guidance amid robust lithium market conditions.

Reach Resources has boosted its Blue Heaven gold resource by roughly 30% to 80,000 ounces, supported by strong metallurgical results and a newly granted mining lease, while progressing a $3.15 million rights issue to fund further exploration and development.

Recharge Metals has completed the acquisition of the Sunset Well Gold Project near Leonora, WA, backed by a $6 million capital raise. The project hosts a 94,500-ounce inferred gold resource with significant exploration upside.

Algorae Pharmaceuticals strengthened its balance sheet with $5.47 million cash reserves and broadened its commercial footprint through new licensing deals and AI-driven drug validation.

Alara Resources maintained steady copper-gold production at its Al Wash-hi Majaza Mine despite regional geopolitical shipping disruptions, while advancing exploration and managing ongoing legal proceedings in Oman.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.